Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
Open Access
- 4 September 2019
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 18 (4) , 12-18
Abstract
Возможности клинического применения нового биомаркера ST2 у больных с хронической сердечной недостаточностью ишемического генеза: тест с физической нагрузкойKeywords
This publication has 9 references indexed in Scilit:
- Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF TrialJournal of Cardiac Failure, 2016
- Biomarkers and Low Risk in Heart Failure. Data from COACH and TRIUMPHEuropean Journal of Heart Failure, 2015
- ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus PanelThe American Journal of Cardiology, 2015
- ST2 Pathogenetic Profile in Ambulatory Heart Failure PatientsJournal of Cardiac Failure, 2015
- Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart FailureJACC: Heart Failure, 2014
- Heart failure and sudden cardiac deathAnnaly aritmologii, 2013
- Multiple Biomarkers for Risk Prediction in Chronic Heart FailureCirculation: Heart Failure, 2012
- Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic DysfunctionJACC, 2009
- Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial InfarctionCirculation, 2008